Understanding how RNA editing works in brain tumors

Molecular mechanisms that regulate ADAR target recognition and RNA editing in vivo

NIH-funded research Trustees of Indiana University · NIH-10825154

This study is looking at how certain proteins help enzymes edit RNA, which is important for how genes work, especially in brain tumors, and it hopes to find new ways to treat these conditions that could help patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTrustees of Indiana University NIH-funded
Lab location1 site (Bloomington, United States)
Project IDNIH-10825154 on NIH RePORTER

What this research studies

This research investigates the molecular mechanisms by which RNA binding proteins influence the recognition of RNA targets by ADAR enzymes, which are crucial for RNA editing. By using both a model organism and human brain tumor cell lines, the research aims to uncover how specific adenosines are edited and how this process affects gene expression. Patients may benefit from insights into the role of RNA editing in brain tumors, potentially leading to new therapeutic strategies. The study employs a combination of biochemistry, genomics, and molecular biology techniques to achieve its goals.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with brain tumors, particularly glioblastomas.

Not a fit: Patients with non-cancerous conditions or those not affected by brain tumors may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for brain tumors by enhancing our understanding of RNA editing mechanisms.

How similar studies have performed: Previous research has shown promising results in understanding RNA editing mechanisms, suggesting that this approach could yield valuable insights.

Where this research is happening

Bloomington, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.